Evidence map›Paper›PMID 27105778›Full record

ArticleEuropean journal of immunology2016

TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.

James E Ussher, Bonnie van Wilgenburg, Rachel F Hannaway, Kerstin Ruustal, Prabhjeet Phalora, Ayako Kurioka, Ted H Hansen, Christian B Willberg, Rodney E Phillips, Paul Klenerman

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.Advances in experimental medicine and biology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Mucosal-associated invariant T cells for cancer immunotherapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

James E UssherPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Bonnie van WilgenburgPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Rachel F HannawayDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Kerstin RuustalPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Prabhjeet PhaloraPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Ayako KuriokaPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Ted H HansenDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Christian B WillbergPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Rodney E PhillipsPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, Oxfordshire, United Kingdom.
University of Oxford · GBJohn Radcliffe Hospital · GBUniversity of Otago · NZWashington University in St. Louis · US

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
NIAID NIH HHS U19 AI082630Wellcome Trust 091663Wellcome Trust 109965/Z/15/Z
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are an abundant innate-like T lymphocyte population that are enriched in liver and mucosal tissues. They are restricted by MR1, which presents antigens derived from a metabolic precursor of riboflavin synthesis, a pathway present in many microbial species, including commensals. Therefore, MR1-mediated MAIT cell activation must be tightly regulated to prevent inappropriate activation and immunopathology. Using an in vitro model of MR1-mediated activation of primary human MAIT cells, we investigated the mechanisms by which it is regulated. Uptake of intact bacteria by antigen presenting cells (APCs) into acidified endolysosomal compartments was required for efficient MR1-mediated MAIT cell activation, while stimulation with soluble ligand was inefficient. Consistent with this, little MR1 was seen at the surface of human monocytic (THP1) and B-cell lines. Activation with a TLR ligand increased the amount of MR1 at the surface of THP1 but not B-cell lines, suggesting differential regulation in different cell types. APC activation and NF-κB signaling were critical for MR1-mediated MAIT cell activation. In primary cells, however, prolonged TLR signaling led to downregulation of MR1-mediated MAIT cell activation. Overall, MR1-mediated MAIT cell activation is a tightly regulated process, dependent on integration of innate signals by APCs.

Indexed as

Signal TransductionAntigen PresentationAntigen-Presenting CellsAntigensBacteriaCell MembraneEndosomesGene ExpressionHistocompatibility Antigens Class IHumansInterleukin-12Interleukin-18LigandsLipopolysaccharidesLymphocyte ActivationMinor Histocompatibility AntigensAntigensHistocompatibility Antigens Class IInterleukin-12Interleukin-18LigandsLipopolysaccharidesMinor Histocompatibility AntigensMR1 protein, humanNF-kappa BToll-Like ReceptorsActivationAntigen presenting cellEndotoxin toleranceMAIT cellsMR1NF-κB

Identifiers

PMID27105778
PMCPMC5297987
OpenAlexW2337233942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.